. . . . . . . . . . . "a(CHEBI:erlotinib) -| p(HGNC:SKP2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "erlotinib treatment led to an increase in p27(KIP1) half-life by inhibiting p27(KIP1) phosphorylation at Thr187 and by down-regulating Skp2 expression." . . "Selventa" . . . . "2014-07-03T14:30:50.432+02:00"^^ . . .